Skip to content

Depression in Pregnant women due to COVID-19 pandemic in India

To assess the impact of COVID-19 pandemic on depression among pregnant women-A cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033545
Enrollment
120
Registered
2021-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

JSS college of Pharmacy Ooty
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Maternal age of 18 years or greater at the time of consent. Gestational week: 32 to 40 weeks (Third trimester) The ability to provide written informed consent.

Exclusion criteria

Exclusion criteria: Pregnant women with the gestational week under six (Early first trimester) Pregnant women with chronic disease like chronic hypertension, kidney and liver disease, pre-pregnancy diabetes mellitus Patient with reported depression in the past History of use of anti-depressants and other drugs which cause depression. History of high-risk pregnancy including abruption placenta, placenta previa, gestational diabetes, coagulation disorders, thrombocytopenia or history of drug abuse. History of autoimmune diseases

Design outcomes

Primary

MeasureTime frame
Whether COVID-19 pandemic is a possible risk factor for the development of depression among the pregnant and non-pregnant women.Timepoint: 6 months

Secondary

MeasureTime frame
Whether the COVID-19 pandemic has an impact on the maternal outcomes at delivery and neonatal outcomes at birthTimepoint: 6 months

Countries

India

Contacts

Public ContactSHONITHA S

JSS COLLEGE OF PHARMACY,OOTY

roopabs@jssuni.edu.in9047155003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026